144 related articles for article (PubMed ID: 33314787)
1. Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A
Iwata Y; Kitajima S; Yamahana J; Shimomura S; Yoneda-Nakagawa S; Sakai N; Furuichi K; Ogura H; Sato K; Toyama T; Yamamura Y; Miyagawa T; Hara A; Shimizu M; Ohkawa R; Kurano M; Yatomi Y; Wada T
Int J Rheum Dis; 2021 Feb; 24(2):231-239. PubMed ID: 33314787
[TBL] [Abstract][Full Text] [Related]
2. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.
Kurano M; Miyagaki T; Miyagawa T; Igarashi K; Shimamoto S; Ikeda H; Aoki J; Sato S; Yatomi Y
J Dermatol; 2018 May; 45(5):571-579. PubMed ID: 29500864
[TBL] [Abstract][Full Text] [Related]
3. Urine autotaxin levels reflect the disease activity of sarcoidosis.
Murakami K; Tamada T; Saigusa D; Miyauchi E; Nara M; Ichinose M; Kurano M; Yatomi Y; Sugiura H
Sci Rep; 2022 Mar; 12(1):4372. PubMed ID: 35288647
[TBL] [Abstract][Full Text] [Related]
4. Serum phosphatidylserine-specific phospholipase A
Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
[TBL] [Abstract][Full Text] [Related]
5. Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy.
Shimizu M; Furuichi K; Toyama T; Yamahana J; Ohkawa R; Igarashi K; Aoki J; Kaneko S; Yatomi Y; Wada T
Intern Med; 2016; 55(3):215-21. PubMed ID: 26831013
[TBL] [Abstract][Full Text] [Related]
6. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
Kurano M; Kano K; Dohi T; Matsumoto H; Igarashi K; Nishikawa M; Ohkawa R; Ikeda H; Miyauchi K; Daida H; Aoki J; Yatomi Y
J Lipid Res; 2017 Feb; 58(2):433-442. PubMed ID: 28007846
[TBL] [Abstract][Full Text] [Related]
7. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism.
Nakawatari K; Kurano M; Araki O; Nishikawa M; Shimamoto S; Igarashi K; Aoki J; Murakami M; Yatomi Y
Clin Chim Acta; 2020 Apr; 503():99-106. PubMed ID: 31978406
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
9. Role of the placenta in serum autotaxin elevation during maternal cholestasis.
Macias RIR; Matilla S; Lozano E; Estiú MC; Oude Elferink RP; Marin JJG
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G399-G407. PubMed ID: 29927323
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.
Wu T; Xie C; Han J; Ye Y; Singh S; Zhou J; Li Y; Ding H; Li QZ; Zhou X; Putterman C; Saxena R; Mohan C
PLoS One; 2016; 11(3):e0151491. PubMed ID: 27019456
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
12. Analysis of glycero-lysophospholipids in gastric cancerous ascites.
Emoto S; Kurano M; Kano K; Matsusaki K; Yamashita H; Nishikawa M; Igarashi K; Ikeda H; Aoki J; Kitayama J; Yatomi Y
J Lipid Res; 2017 Apr; 58(4):763-771. PubMed ID: 28143894
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma.
Uranbileg B; Kurano M; Sato M; Ikeda H; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
Sci Rep; 2020 Feb; 10(1):2659. PubMed ID: 32060356
[TBL] [Abstract][Full Text] [Related]
14. Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.
Yu KYC; Yung S; Chau MKM; Tang CSO; Yap DYH; Tang AHN; Ying SKY; Lee CK; Chan TM
Rheumatology (Oxford); 2021 Feb; 60(2):737-750. PubMed ID: 32793966
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
[TBL] [Abstract][Full Text] [Related]
18. Low level of circulating basophil counts in biopsy-proven active lupus nephritis.
Liang P; Tang Y; Lin L; Zhong H; Yang H; Zeng Y; Lv J; Li X; Lu Y; Xu A
Clin Rheumatol; 2018 Feb; 37(2):459-465. PubMed ID: 28988406
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasis.
Iida Y; Sunami E; Yamashita H; Hiyoshi M; Ishihara S; Yamaguchi H; Inoue A; Makide K; Tsuno NH; Aoki J; Kitayama J; Watanabe T
Anticancer Res; 2015 Mar; 35(3):1459-64. PubMed ID: 25750298
[TBL] [Abstract][Full Text] [Related]
20. High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis.
Carvalho JF; Viana VS; Borba EF; do Nascimento AP; Leon EP; Testagrossa LA; Barros RT; Bonfá E
Clin Rheumatol; 2008 Nov; 27(11):1417-21. PubMed ID: 18523820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
